(−)-Gossypol has recently been discovered to be a powerful Bcl-2 and Bcl-xL inhibitor, which may increase the response of prostate cancer to radiation by potentiating radiation-induced apoptosis. Here, BCL2 is linked to Familial prostate cancer.